Thrombomodulin-expressing monocytes are associated with low-risk features in myelodysplastic syndromes and dampen excessive immune activation.

van Leeuwen-Kerkhoff, Nathalie; Westers, Theresia M; Poddighe, Pino J; de Gruijl, Tanja D; Kordasti, Shahram; van de Loosdrecht, Arjan A

van Leeuwen-Kerkhoff, Nathalie; Westers, Theresia M; Poddighe, Pino J; de Gruijl, Tanja D; Kordasti, Shahram; van de Loosdrecht, Arjan A.

Afiliación

van Leeuwen-Kerkhoff N; Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam, the Netherlands.
Westers TM; Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam, the Netherlands.
Poddighe PJ; Department of Clinical Genetics, Amsterdam UMC, Amsterdam, the Netherlands.
de Gruijl TD; Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, the Netherlands.
Kordasti S; Comprehensive Cancer Center, King's College London and Guy's Hospital, London, UK.
van de Loosdrecht AA; Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam, the Netherlands a.vandeloosdrecht@vumc.nl.

Haematologica ; 105(4): 961-971, 2020 04.

Article en En | MEDLINE | ID: mdl-31273091

Asunto(s)

Monocitos; Síndromes Mielodisplásicos; Médula Ósea; Progresión de la Enfermedad; Humanos; Trombomodulina/genética

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Monocitos Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google